Shoujun Sun

Shoujun Sun

Auto-generated profile, based on publicly available information

Shoujun Sun

Cold Spring Harbor Laboratory

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AOAlessandra Ottonello
Alessandra Ottonello
JWJessica A. Wyllie
Jessica A. Wyllie
OYOussama Yahiaoui
Oussama Yahiaoui
SSShoujun Sun
Shoujun Sun
RKRebecca A. Koelln
Rebecca A. Koelln
JMJohn Edward Moses
John Edward Moses
The alarming rise in superbugs that are resistant to drugs of last resort, including vancomycin-resistant enterococci and staphylococci, has become a significant global health hazard. Here, we report the click chemistry synthesis of an unprecedented class of shapeshifting vancomycin dimers (SVDs) that display potent activity against bacteria that are resistant to the parent drug, including the ESKAPE pathogens, vancomycin-resistant Enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), as well as vancomycin-resistant S. aureus (VRSA). The shapeshifting modality of the dimers is powered by a triazole-linked bullvalene core, exploiting the dynamic covalent rearrangements of the fluxional carbon cage and creating ligands with the capacity to inhibit bacterial cell wall biosynthesis. The new shapeshifting antibiotics are not disadvantaged by the common mechanism of vancomycin resistance resulting from the alteration of the C-terminal dipeptide with the corresponding d -Ala- d -Lac depsipeptide. Further, evidence suggests that the shapeshifting ligands destabilize the complex formed between the flippase MurJ and lipid II, implying the potential for a new mode of action for polyvalent glycopeptides. The SVDs show little propensity for acquired resistance by enterococci, suggesting that this new class of shapeshifting antibiotic will display durable antimicrobial activity not prone to rapidly acquired clinical resistance.

22 January 2025 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
ZWZifei Wang
Zifei Wang
DVDharmendra S. Vishwakarma
Dharmendra S. Vishwakarma
SSShoujun Sun
Shoujun Sun
QHQiyao Huang
Qiyao Huang
SPSoumyaranjan Pati
Soumyaranjan Pati
JMJohn Edward Moses
John Edward Moses

11 September 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
SSShoujun Sun
Shoujun Sun
ESElliot J. Smith
Elliot J. Smith
DVDharmendra Vishwakarma
Dharmendra Vishwakarma
AMAdam D. Moorhouse
Adam D. Moorhouse
JMJohn Edward Moses
John Edward Moses
We introduce germanium into the click chemistry family through the development of Germanium(IV) Fluoride Exchange-S (GeFEx-S), a thiol-selective reaction that enables rapid covalent bond formation under mild, “on-water” conditions. This transformation leverages the unique reactivity of tetravalent fluorogermanes to generate hydrolytically stable Ge–S linkages under biologically relevant conditions. GeFEx-S exhibits broad functional group tolerance - including compatibility with free cysteine residues - and operates orthogonally to established SuFEx and PFEx chemistries. By forming stable Ge–S bonds under aqueous conditions, GeFEx-S expands the fluoride exchange repertoire and establishes a versatile platform for site-selective bioconjugation, chemical probe development, and orthogonal functionalization in chemical biology and materials science.